ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,692Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 262

$492K Total Retail Price of All Prescriptions

Rank: 22 out of 262

481 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 429 395 1 4
LEVOTHYROXINE SODIUM 428 386 2 2
OMEPRAZOLE 422 366 3 5
POTASSIUM CHLORIDE 368 365 4 10
LISINOPRIL 351 294 5 3
AMLODIPINE BESYLATE 289 258 6 6
METOPROLOL TARTRATE 281 267 7 8
SIMVASTATIN 237 223 8 1
WARFARIN SODIUM 227 200 9 12
HYDROCHLOROTHIAZIDE 209 206 10 7
SERTRALINE HCL 201 187 11 14
ATORVASTATIN CALCIUM 184 159 12 13
METOPROLOL SUCCINATE 169 169 13 11
METFORMIN HCL 158 156 14 9
FENTANYL 157 157 S2 15 40
GABAPENTIN 142 139 16 19
HYDROCODONE-ACETAMINOPHEN 130 126 S3 17 15
ATENOLOL 129 123 18 16
CIPROFLOXACIN HCL 127 115 19 55
DIGOXIN 125 125 20 28
ALLOPURINOL 118 105 21 22
TAMSULOSIN HCL 113 108 22 25
DONEPEZIL HCL 108 108 23 23
DIOVAN 105 99 24 47
MIRTAZAPINE 101 98 25 35
TRAMADOL HCL 98 97 26 18
BENAZEPRIL HCL 90 90 27 99
RAMIPRIL 83 83 28 78
ISOSORBIDE MONONITRATE ER 79 79 29 33
BYSTOLIC 77 74 30 123
NEXIUM 75 75 31 57
AMOXICILLIN 73 71 32 146
CLOPIDOGREL 72 69 33 38
VENLAFAXINE HCL ER 72 66 33 79
PREDNISONE 72 72 33 29
DILTIAZEM 24HR ER 71 71 36 114
CYMBALTA 70 70 37 67
DIOVAN HCT 69 69 38 103
CRESTOR 65 65 39 30
POLYETHYLENE GLYCOL 3350 64 43 40 42
DOXAZOSIN MESYLATE 64 64 40 59
LOSARTAN POTASSIUM 63 63 42 17
ESCITALOPRAM OXALATE 60 56 43 83
METOLAZONE 59 59 44 141
LIPITOR 59 54 44 96
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 44 81
NAMENDA 58 58 47 37
GLIMEPIRIDE 57 54 48 45
GEMFIBROZIL 56 56 49 92
LYRICA 53 43 50 86
VESICARE 52 40 51 138
CEPHALEXIN 52 45 51 69
CELEBREX 51 49 53 91
QUETIAPINE FUMARATE 50 50 54 71
TRIAMTERENE-HCTZ 50 50 54 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.